Future Virology

Papers
(The TQCC of Future Virology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Short Hairpin RNA-Mediated Matrix Gene Silencing of Human Respiratory Syncytial Virus as a Potent Antiviral Strategy82
Inpatient and Outpatient Costs Associated With Respiratory Syncytial Virus in Japanese Infants and Older Adults43
Proteomics insights into Zika virus infection29
Spillover of rat hepatitis E virus into humans: an emerging zoonosis?26
Analysis of the application value of HPV mRNA and DNA detection in early screening of cervical lesions23
Association Between Human Herpesvirus-6 and Primary Brain Tumors: A Systematic Review and Meta-Analysis22
Evaluation of Rapid Antigen Detection Kits for the Detection of SARS-CoV-2 B.1.617.2 Virus22
The Mu Strain: The Last but not Least Circulating ‘Variant of Interest’ Potentially Affecting the COVID-19 Pandemic21
Computed tomography-positive, SARS-CoV-2 RNA-negative Symptomatic Contacts of COVID-19 Patients: What are Their Nature and implications?19
N6-methyladenosine Methylation of Viral Genes19
Coping with the Third wave of the COVID-19 Pandemic in Africa: Implications for an Improved Outbreak Response16
Digging for the Discovery of SARS-CoV-2 nsp12 Inhibitors: A Pharmacophore-Based and Molecular Dynamics Simulation Study16
Rosmarinic Acid Inhibits Rift Valley Fever Virus: In Vitro , Computational and Analytical Studies15
The Association of De Ritis Ratio with the Severity of Crimean–Congo Hemorrhagic Fever14
Beyond Vaccination: Prognostic Value of p16-HPV Testing in Squamous Cell Cervical Cancer12
Harnessing the power of the community to increase vaccination among homeless populations in inner-city Vancouver11
Corrigendum11
The Role of Quasi-Enveloped Hepatitis A Virus in Hepatitis A Virus⟉nfection10
Ultrapure and potent tannic acid as a pluripotent protease and influenza HA inhibitor against influenza virus infection10
Real-world Effectiveness of sofosbuvir/velpatasvir for the Treatment of Hepatitis C Virus in Prison Settings10
Cs-GRP78 Recognition Site on Dengue Virus Envelope Protein:in silicoperspective10
Antineutrophil Cytoplasmic Antibody Positivity and Clinical Implications in COVID-199
Altered Synaptic Plasticity: Plausible Mechanisms Associated With Viral Infections9
Hepatitis E Virus Genotyping in Pakistan: A Regional Study to Explore the Implications for Pregnant Females8
Direct Virus Capture Assay for Label-Free Detection of SARS-CoV-2 Virions Using Laser Microscopy8
A Brief Review on Dna Vaccines in the Era of COVID-198
Trends and Perspectives in Tuberculosis and HIV Co-Infection Studies Over the Past Three Decades8
In silico analysis of ACE2 from different animal species provides new insights into SARS-CoV-2 species spillover8
Modulatory effects of Eucalyptus spp. essential oils and eucalyptol on cytokines and antiviral activity against SARS-CoV-28
HIV Infection and the Risk of Cancer: Tumorigenicity of HIV-1 Auxiliary Proteins8
Neurofilament light chain as a biomarker for neurodegenerative changes in COVID-19 and clinical implications7
Kuwanon X from Mulberry Leaves Exhibits Antiviral Activity Against Human Adenoviruses7
G-Quadruplexes in hemorrhagic fever viruses of Bunyavirales7
Sudden Onset of Decreased Vision Following Delta Variant of SARS-CoV-2 Infection: A Case Report7
Drug evaluation: maribavir as a cytomegalovirus antiviral agent6
Rift Valley Fever Virus: A New Avenue of Research On the Biological Functions of amyloids?6
Decreased Efficacy of Sofosbuvir/Velpatasvir in HIV Patients Coinfected with HCV Genotype 3b6
Expression of miR-203 and Its Target Genes in Condyloma Acuminatum and Their Relationships With Clinical Recurrence6
Similarity Between Cutaneous Reactions Due to SARS-CoV-2 and Its Vaccinations6
Are Ruminants and Their Products Potential Sources of Human Hepatitis E Virus infection?6
Expression of TRIM56 Gene in SARS-CoV-2 Variants and its Relationship with Progression of COVID-196
Respiratory Syncytial Virus: An Overview6
Association between chronic hepatitis B virus infection and premature ejaculation in a Turkish population6
Tripartite Communication in COVID-19 Infection: SARS-CoV-2 Pathogenesis, Gut Microbiota and ACE25
Screening and Identification of Dominant B-cell Epitopes of Human Cytomegalovirus UL138 and Its Clinical Applications5
COVID-19 Post Vaccination Neuronal Adverse Events: Probable Mechanisms and Treatment Possibilities5
The Need for More Robust Research On the Effectiveness of Masks in Preventing COVID-19 Transmission5
Characterization of a virulent bacteriophage consortium targeting Enterobacteriaceae from inflamed preterm gut mucosa5
Circulation of Mumps Virus Genotype G in Pakistan During 2023 Outbreak5
Conference Proceedings From the 26th Bangkok International Symposium on HIV Medicine5
Analysis of gene expression differences pre- and post-lytic reactivation of Epstein–Barr virus in Burkitt's lymphoma5
The Effects of Herpes Virus Glycoprotein Glycosylation On Viral Infection and Pathogenesis5
RT-LAMP is a Potential Future Molecular Diagnostic Tool for Influenza A Virus4
Myocarditis and COVID-19 Mrna Vaccines: A Mechanistic Hypothesis Involving dsRNA4
Detection of Occult Hepatitis B Virus in Patients Undergoing Chemotherapy in Iran4
Hepatitis E Virus Infection During Pregnancy in South Asian Countries: Why is Mortality So high?4
Detection and Predictors of anti-SARS-CoV-2 Antibody Levels in COVID-19 Patients at 8 Months After Symptom Onset4
High-value Laboratory Testing for Hospitalized COVID-19 Patients: A Review4
Effectiveness⟡nd Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Therapy in an Observational Italian Cohort: The DIAMANTE Study4
The Prevalence of Deep Vein Thrombosis and Associated Risk Factors Among Patients with COVID-19 in the North of Iran4
COVID-19 treatment that contains ritonavir may interact with other drugs: a plain language summary4
Detection of SARS-CoV-2 N501Y Mutation Among SARS-CoV-2 Variants of Concern Circulating in Northern Cyprus4
Development of an Epitope-Based Chimeric Protein As a Vaccine Against Lujo Virus By Utilizing Immunoinformatic Tools4
IgA Nephropathy and Spinal Epidural Abscess After COVID-19 Infection: A Case Report4
Targeting ‘Immunogenic Hotspots’ in Dengue and Zika Virus: An in Silico Approach to a Common Vaccine Candidate4
Management of hepatitis B virus (HBV) infection in multiple sclerosis patients on disease modifying therapies (DMTs)4
Viral Etiology of Acute Respiratory Infections During 2014–2016 in Riyadh, Saudi Arabia4
Genomic epidemiology and phylogeographic dynamics of SARS-CoV-2 during the sixth wave and post-sixth wave in Pakistan4
Antiviral Evaluation of 1,4-disubstituted-1,2,3-triazole Derivatives Against Chikungunya Virus4
Detection of SARS-CoV-2 in the Sewerage System in Tunisia: A Promising Tool to Confront COVID-19 Pandemic4
GSTP , GSTT1 , XRCC1 and CASP8 Genetic Variations are Associated with Human Papillomavir4
Ultradiluted Eupatorium perfoliatum Alleviates DENV-induced Fibrosis By Regulation of TGFβ1, MMP-9 and Interferons3
A Plain Language Summary of the Janssen COVID-19 Vaccine Effectiveness and Safety as a Single Dose and with a Booster3
Recombinant Newcastle Disease Virus kills Liver Cancer in Vitro and in Vivo3
Development and evaluation of MMIRA-CRISPR/Cas13a-MBQD assay for the detection of influenza A/B viruses and SARS-CoV-23
A Case Report of Dengue Shock Syndrome Complicated with Multi-Organ Failure and Hepatitis E Virus Superinfection3
Associations between chronic hepatitis B infection and inflammatory bowel diseases in East Asian populations3
Effect of the COVID-19 Pandemic on the Reporting of Crimean–Congo Hemorrhagic Fever3
Analysis of Virologic Outcome in low-level HIV-1 Viremia Patients in a Small Cohort3
Role of Oxidative Stress in the Epstein–Barr Virus Lifecycle and Tumorigenicity3
Novel Chimeric Vectors Harboring Hepatitis B Viral Promoter and Reporter Gene Demonstrated Liver-Specific Significance3
The Novel Antiviral Properties of Brassicasterol Against Human Adenovirus3
Corrigendum3
0.046548843383789